Latest Content

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Standard double reading did not perform as well as artificial intelligence for looking at catching cancer and reduced the rate of breast cancer diagnosis by 12%.

Vivian Shi, MD, discusses the evolving strategies for managing hidradenitis suppurativa, including biologics and combination therapies, at Maui Derm 2026.

Better integration of pharma and medical technology is necessary to enhance patient outcomes and drive value-based care.

Disparities in access to allo-HCT for AML persist, highlighting the need for targeted interventions to ensure equitable treatment for all patients.

This new study reveals venetoclax and rituximab effectively treat chronic lymphocytic leukemia, showing high response rates and prolonged progression-free survival.

A Maui Derm 2026 session explored advancements in pediatric dermatology, emphasizing precision medicine and targeted therapies for children.

Participants in the pilot program had high baseline knowledge about their chronic spontaneous urticaria, but the same was not always true of their physicians.